{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:31:10Z","timestamp":1787902270615,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T00:00:00Z","timestamp":1505347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["GACR P304\/12\/G069"],"award-info":[{"award-number":["GACR P304\/12\/G069"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program InterAction","award":["LTAUSA17120"],"award-info":[{"award-number":["LTAUSA17120"]}]},{"name":"EATRIS-CZ","award":["LM2015064"],"award-info":[{"award-number":["LM2015064"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.neuropharm.2017.09.006","type":"journal-article","created":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T14:16:34Z","timestamp":1504966594000},"page":"213-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["A green tea polyphenol epigallocatechin-3-gallate enhances neuroregeneration after spinal cord injury by altering levels of inflammatory cytokines"],"prefix":"10.1016","volume":"126","author":[{"given":"Lucia","family":"Machova Urdzikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Karova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kloudova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Svobodova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Dubisova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meic","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarka","family":"Kubinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Jhanwar-Uniyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Jendelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2017.09.006_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2005.12.024","article-title":"(-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain","volume":"531","author":"Adachi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2017.09.006_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ejp.722","article-title":"Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice","volume":"20","author":"Alvarez-Perez","year":"2016","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.09.006_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4097\/kjae.2014.67.2.123","article-title":"Antiallodynic effect of intrathecal epigallocatechin-3-gallate due to suppression of reactive oxygen species","volume":"67","author":"An","year":"2014","journal-title":"Korean J. Anesthesiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1995.12.1","article-title":"A\u00a0sensitive and reliable locomotor rating scale for open field testing in rats","volume":"12","author":"Basso","year":"1995","journal-title":"J.\u00a0Neurotrauma"},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease","volume":"326","author":"Begum","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/107555303321223035","article-title":"Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)","volume":"9","author":"Chainani-Wu","year":"2003","journal-title":"J.\u00a0Altern. Complement. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2011.12.070","article-title":"Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model","volume":"510","author":"Choi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.09.006_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2013.06.009","article-title":"Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats","volume":"1527","author":"Ge","year":"2013","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2017.09.006_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-kappaB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.09.006_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/brb3.172","article-title":"Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury","volume":"4","author":"Goldshmit","year":"2014","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.09.006_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10790268.1997.11719469","article-title":"Axonal sprouting following incomplete spinal cord injury: an experimental model","volume":"20","author":"Goldstein","year":"1997","journal-title":"J.\u00a0Spinal Cord. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jnc.12964","article-title":"Polyphenols from green tea prevent antineuritogenic action of Nogo-A via 67-kDa laminin receptor and hydrogen peroxide","volume":"132","author":"Gundimeda","year":"2015","journal-title":"J.\u00a0Neurochem."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.09.006_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jn\/136.4.1043","article-title":"Long-term administration of green tea catechins improves spatial cognition learning ability in rats","volume":"136","author":"Haque","year":"2006","journal-title":"J.\u00a0Nutr."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.09.006_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2012.05.002","article-title":"UCP4 is a target effector of the NF-kappaB c-Rel prosurvival pathway against oxidative stress","volume":"53","author":"Ho","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2017.09.006_bib16","first-page":"31","article-title":"Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat","volume":"15","author":"Khalatbary","year":"2011","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.neuropharm.2017.09.006_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2009.09.109","article-title":"Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats","volume":"1306","author":"Khalatbary","year":"2010","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2017.09.006_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2011.11.037","article-title":"Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats","volume":"676","author":"Kuang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010049","article-title":"The anti-inflammatory compound curcumin enhances locomotor and sensory recovery after spinal cord injury in rats by immunomodulation","volume":"17","author":"Machova Urdzikova","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib36","doi-asserted-by":"crossref","first-page":"e0148001","DOI":"10.1371\/journal.pone.0148001","article-title":"Call off the Dog(ma): M1\/M2 polarization is concurrent following traumatic brain injury","volume":"11","author":"Morganti","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.neuropharm.2017.09.006_bib20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jnutbio.2009.08.009","article-title":"Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia","volume":"21","author":"Park","year":"2010","journal-title":"J.\u00a0Nutr. Biochem."},{"issue":"9","key":"10.1016\/j.neuropharm.2017.09.006_bib21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.biocel.2008.03.009","article-title":"Spinal cord injury: emerging beneficial role of reactive astrocytes' migration","volume":"40","author":"Renault-Mihara","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.09.006_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2013.09.013","article-title":"(-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats","volume":"77","author":"Renno","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2017.09.006_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/neu.2014.3491","article-title":"(-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury","volume":"32","author":"Renno","year":"2015","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2017.09.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2015.10.029","article-title":"Is there a role for neurotrophic factors and their receptors in augmenting the neuroprotective effect of (-)-epigallocatechin-3-gallate treatment of sciatic nerve crush injury?","volume":"102","author":"Renno","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2017.09.006_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000265946","article-title":"Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism","volume":"7","author":"Reznichenko","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2017.09.006_bib37","article-title":"Recent updates in imperative natural compounds for healthy brain and nerve function: a systematic review of implications for multiple sclerosis","author":"Sanadgol","year":"2016","journal-title":"Curr. Drug Targets"},{"issue":"24 Suppl","key":"10.1016\/j.neuropharm.2017.09.006_bib26","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00007632-200112151-00002","article-title":"Epidemiology, demographics, and pathophysiology of acute spinal cord injury","volume":"26","author":"Sekhon","year":"2001","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4196\/kjpp.2016.20.1.41","article-title":"Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-kappaB signaling pathway in mice","volume":"20","author":"Seong","year":"2016","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.09.006_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2015.06.035","article-title":"(-)Epigallocatechin-3-gallate decreases the stress-induced impairment of learning and memory in rats","volume":"602","author":"Soung","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.09.006_bib28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s11064-013-0976-5","article-title":"Intrathecal epigallocatechin gallate treatment improves functional recovery after spinal cord injury by upregulating the expression of BDNF and GDNF","volume":"38","author":"Tian","year":"2013","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.09.006_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.sc.3101792","article-title":"Post-traumatic moderate systemic hyperthermia worsens behavioural outcome after spinal cord injury in the rat","volume":"44","author":"Urdzikova","year":"2006","journal-title":"Spinal Cord."},{"issue":"12","key":"10.1016\/j.neuropharm.2017.09.006_bib39","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1089\/08977150152725687","article-title":"A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat","volume":"18","author":"Vanicky","year":"2001","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.09.006_bib30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-140981","article-title":"Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model","volume":"44","author":"Walker","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuropharm.2017.09.006_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bbrc.2015.06.146","article-title":"VEGF inhibits the inflammation in spinal cord injury through activation of autophagy","volume":"464","author":"Wang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2017.09.006_bib32","doi-asserted-by":"crossref","first-page":"e0123122","DOI":"10.1371\/journal.pone.0123122","article-title":"Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice","volume":"10","author":"Xifro","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.neuropharm.2017.09.006_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11064-006-9166-z","article-title":"Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Xu","year":"2006","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.09.006_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcp.2006.03.022","article-title":"Inhibition of homodimerization of Toll-like receptor 4 by curcumin","volume":"72","author":"Youn","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.neuropharm.2017.09.006_bib35","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.febslet.2010.05.011","article-title":"Epigallocatechin-3-gallate protects motor neurons and regulates glutamate level","volume":"584","author":"Yu","year":"2010","journal-title":"FEBS Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T04:21:32Z","timestamp":1570076492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817304203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":39,"alternative-id":["S0028390817304203"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A green tea polyphenol epigallocatechin-3-gallate enhances neuroregeneration after spinal cord injury by altering levels of inflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}